Such studies might include assessment of PDL1/PDL2 gene gains and protein expression in tumour cells, which are noted to be absent in LP cells of typical NLPHL cases but present in THRLBCL tumour cells (35, 39, 40). The gene discussed is CD274; the disease is neoplasm.